- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01164592
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation (MS)
SERVE-HF: Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This substudy is performed within the SERVE-HF Study, a randomised, multi-centre,international trial with parallel group design, with patients randomised to either control (optimal medical management) or active treatment (optimal medical treatment plus use of adaptive servoventilation) in a 1:1 ratio. The randomization will be the same as in the parent study. For this purpose, the randomization of the parent study will be stratified as to whether a patient is included in the substudy or not. 300 patients will be recruited for the substudy overall.
For the purpose of this substudy, patients will be followed up for a period of 12 months.
The following extra tests will be performed at the baseline visit, the 3 months follow up and the 12 months follow up:
- Echocardiogram (for both groups)
- cMRI (for both groups)
- PSG (at the baseline visit only for patients in the treatment group and at 3 months follow up and the 12 months follow up for all patients)
- 4 questionnaires (for both groups)
- Additional blood testing (for both groups)
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
New South Wales
-
Westmead, New South Wales, Australia, 2145
- Westmead Hospital
-
-
Queensland
-
Auchenflower, Queensland, Australia, 4066
- Rivercity Private Hospital
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Royal Adelaide Hospital
-
-
Victoria
-
East Melbourne, Victoria, Australia, 3002
- Melbourne Sleep Disorders Centre
-
Melbourne, Victoria, Australia, 3065
- St. Vincents and Mercy Private Hospital
-
-
Western Australia
-
Nedlands, Western Australia, Australia, 6009
- Hollywood Private Hospital (CVS)
-
-
-
-
-
Brno, Czech Republic, 65691
- St. Anne's University Hospital
-
-
-
-
-
Helsinki, Finland, 00290
- Helsinki University Hospital
-
Tampere, Finland, 33520
- Unesta Research Centre
-
Tampere, Finland, 33521
- Tampere University Hospital, Pirkanmaa sairaanhoitopiiri
-
-
-
-
-
Grenoble, France, 38000
- Clinique Mutualiste des Eaux Claires
-
Grenoble, France, 38043
- CHU Grenoble, Hopital Michallon
-
Poitiers, France, 86000
- CHU de Poitiers
-
-
-
-
-
Aachen, Germany, 52074
- Universitätsklinikum Aachen
-
Alzey, Germany, 55232
- DRK Krankenhaus
-
Bad Krozingen, Germany, 79189
- Herzzentrum Bad Krozingen
-
Bad Oeynhausen, Germany, 32545
- Herz- und Diabeteszentrum NRW
-
Berlin, Germany, 12683
- Unfallkrankenhaus Berlin
-
Berlin, Germany, 10117
- Charité Campus Mitte
-
Berlin, Germany, 10117
- Charité Campus Mitte CCM
-
Berlin, Germany, 12157
- POLIKUM Friedenau
-
Berlin, Germany, 13347
- Jüdisches Krankenhaus Berlin
-
Bielefeld, Germany, 33617
- Praxis für Lunge Herz und Schlaf
-
Bonn, Germany, 53225
- Kardiologische Praxis Marschner
-
Borna, Germany, 04552
- Helios Klinikum Borna
-
Brühl, Germany, 50321
- Kardiologie Brühl
-
Castrop-Rauxel, Germany, 44575
- Gemeinschaftspraxis Kardiologie Dr. Becker
-
Castrop-Rauxel, Germany, 44577
- Kardiologische Praxis Dr. Isbruch
-
Dortmund, Germany, 44135
- Praxis Dr. Hecker
-
Dortmund, Germany, 44141
- Kardiologische Praxis Dr. Wetzel
-
Dortmund, Germany, 44147
- Praxis Dr. Lodde
-
Dresden, Germany, 01099
- Facharztzentrum Dresden-Neustadt GbR
-
Dresden, Germany, 01219
- Gemeinschaftpraxis Dres. Schmidt/Gronke
-
Dresden, Germany, 01277
- Praxis Dr. Hohensee
-
Dresden, Germany, 01307
- Herzzentrum Universität Dresden
-
Duesseldorf, Germany, 40489
- Khs Florence-Nightingale
-
Düsseldorf, Germany, 40545
- Kardiologie Oberkassel
-
Düsseldorf, Germany, 40597
- Gemeinschaftspraxis PD Dr. Lankisch
-
Essen, Germany, 45122
- Universitätsklinikum Essen
-
Essen, Germany, 45239
- Ruhrlandklinik Essen
-
Essen, Germany, 45136
- Kardiologie Praxis Dr. Bonnekamp
-
Essen, Germany, 45136
- Praxis Dr. Tekiyeh
-
Essen, Germany, 45359
- Kath. Kliniken Essen/ Philippusstift
-
Flonheim, Germany, 55237
- Gemeinschaftspraxis Dres. Guckenbiehl
-
Frankfurt, Germany, 60389
- CardioVaskuläres Centrum Frankfurt
-
Frechen, Germany, 50226
- Praxis Dr. Diedrichs
-
Freiburg im Breisgau, Germany, 79106
- Universitätsklinikum Freiburg
-
Gütersloh, Germany, 33330
- Kardiologische Praxis Gütersloh
-
Hagen, Germany, 58095
- Gemeinschaftspraxis Dres Leischik/Littwitz
-
Hamburg, Germany, 20246
- Universitätsklinikum Hamburg-Eppendorf
-
Hamburg, Germany, 22291
- Asklepios Klinik Barmbek
-
Heidelberg, Germany, 69120
- Universitätsklinikum Heidelberg
-
Heidelberg, Germany, 69126
- Thoraxklinik Heidelberg gGmbH
-
Hemer, Germany, 58675
- Lungenklinik Hemer
-
Herne, Germany, 44629
- Gemeinschaftspraxis Dr. Bruch
-
Herne, Germany, 44649
- Kardiologische Praxis Dr. Schlichting
-
Herne, Germany, 44623
- B&B GmbH
-
Herne, Germany, 44623
- Cardio-Praxis Herne Dr. Furche
-
Herne, Germany, 44651
- Augusta-Kranken-Anstalt gGmbH Thoraxzentrum Ruhrgebiet
-
Herten, Germany, 45699
- St. Elisabeth-Hospital Herten gGmbH
-
Immenhausen, Germany, 34376
- Lungenfachklinik Immenhausen
-
Ingelheim, Germany, 55218
- Cardiopraxis Ingelheim
-
Karlstadt, Germany, 97753
- Gemeinschaftspraxis Dres. Dobler/Turin
-
Köln, Germany, 50931
- Malteser Krankenhaus St. Hildegardis
-
Köln, Germany, 50937
- Klinikum der Universität zu Köln- Herzzentrum
-
Köln, Germany, 51065
- Praxis Dr. Anselm Bäumer
-
Köln, Germany, 51105
- Gemeinschaftspraxis Dres. Gysan/Heinzler/May
-
Köln, Germany, 50937
- Klinikum der Universität zu Köln-Schlaflabor
-
Leipzig, Germany, 04289
- Universität Leipzig -Herzzentrum
-
Lübeck, Germany, 23538
- Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie
-
Lübeck, Germany, 23538
- Universitätsklinikum Schleswig-Holstein Campus Lübeck-Schlaflabor
-
Menden, Germany, 58706
- Praxis Für Kardiologie Dr. med. Menz
-
Moers, Germany, 47441
- Krankenhaus Bethanien
-
Mühldorf, Germany, 84453
- Kardiologische Praxis Dr. Schön
-
Mülheim an der Ruhr, Germany, 45468
- Evangelisches Krankenhaus Mülheim
-
München, Germany, 81375
- Klinikum Augustinum München
-
München, Germany, 80634
- Lungenärzte am Rotkreuzplatz
-
Münster, Germany, 48149
- Universitätsklinikum Münster
-
Neuss, Germany, 41472
- Städtisches Khs Lukas
-
Nienburg, Germany, 31582
- Kardiologische Praxis Nienburg
-
Ratingen, Germany, 40885
- Praxis Dr. Fröhlich
-
Regensburg, Germany, 93053
- Universitätsklinikum Regensburg
-
Reinbek, Germany, 21465
- Khs St. Adolf Stift
-
Reinbek, Germany, 21465
- Praxis Dr. Hein
-
Unna, Germany, 59423
- Katharinen Hospital Unna
-
Waldkraiburg, Germany, 84478
- Praxis Dr. Gerritsen
-
Wiesbaden, Germany, 65183
- Kardiologisch angiologische Gemeinschaftspraxis
-
Wiesbaden, Germany, 65183
- Kardiologische Gemeinschaftspraxis Dr. K. Vorbeck
-
Wuerzburg, Germany, 97074
- Missionsärztliche Klinik Würzburg
-
Würzburg, Germany, 97080
- Comprehensive Heart Failure Center, Universitätsklinikum Würzburg
-
-
-
-
-
Groningen, Netherlands, 9700 RB
- University Medical Center Groningen
-
-
-
-
-
Lugano, Switzerland, 6900
- Cardiocentro Ticino
-
Lugano, Switzerland, 6903
- Ospedale Regionale di Lugano
-
-
-
-
-
London, United Kingdom, UK-SW36NP
- Brompton Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
The inclusion and exclusion criteria are mainly those applicable for the parent study; SERVE-HF. The inclusion and exclusion criteria are listed here.
INCLUSION CRITERIA FOR SERVE-HF STUDY:
- Over 22 years of age
- Severe Chronic Heart Failure (CHF) with NYHA class III-IV or NYHA class II with at least one hospitalisation for HF within the last 24 months
- Left ventricular ejection fraction (LVEF) less than or equal to 45% by means of echocardiography, radionucleotide angiography, left ventriculography or cardiac MRI documented less than 12 weeks before randomisation
- Diagnosis of sleep disordered breathing (SDB) with an apnoea-hypopnoea-index (AHI) of >15/hr with at least 50% central events and a central AHI of at least 10/hr
- Clinically stable with no change in medication and no unplanned hospitalisation for heart failure in preceding month
- Optimised medical treatment according to the applicable guidelines
- Able to provide informed consent
ADDITIONAL INCLUSION CRITERIA FOR THE SUBSTUDY
• Predominant central sleep apnoea (apnoea hypopnoea index > 15/hour with ≥ 50% central events and a central AHI ≥10/hour, derived from full polysomnography (based on total sleep time), documented less than 4 weeks before randomization. Flow measurements have to be performed with nasal cannula
EXCLUSION CRITERIA FOR THE SERVE-HF STUDY:
- Significant chronic obstructive pulmonary disease (COPD) with Forced Expiratory Volume within one second (FEV1)<50% predicted
- Oxygen saturation at rest during the day 90% at the time of inclusion
- Current use of Positive Airway Pressure (PAP) therapy
- Life expectancy < 1 year for diseases unrelated to chronic heart failure
- Cardiac surgery, Percutaneous coronary intervention (PCI), Myocardial Infarction (MI) or unstable angina within 6 months prior to randomisation
- Implantation of ICD (implanted cardiodefibrillator) or CRT (cardiac resynchronisation therapy) scheduled or within 6 months prior to randomisation
- Transient ischemic attack (TIA) or Stroke within 3 months prior to randomisation
- Primary hemodynamically significant uncorrected valvular heart disease, obstructive or regurgitant, or any valvular disease expected to lead to surgery during the trial
- Acute myocarditis/pericarditis within 6 months prior to randomisation
- Untreated or therapy refractory Restless legs Syndrome (RLS)
- Pregnancy
ADDITIONAL EXCLUSION CRITERIA FOR THE SUBSTUDY
- Amyloidosis, hypertrophic obstructive cardiomyopathy or arteriovenous fistulas
- Dosage changes of diuretics more than doubled within the last 4 weeks prior to randomisation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Therapy with adaptive servo ventilation
optimal medical therapy + adaptive servoventilation
|
Patients randomised to therapygroup should use the adaptive servoventilation (ASV) device each night at least 3 hours
Other Names:
|
NO_INTERVENTION: Optimal medical therapy according to guidelines
optimal medical therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Left Ventricular Ejection Fraction (LVEF) from baseline to 12 months of therapy as measured by echocardiography (Echo).
Time Frame: Baseline (Randomization), 6- and 12 month-Follow-up-visit
|
Baseline (Randomization), 6- and 12 month-Follow-up-visit
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in left and right ventricular function
Time Frame: Baseline (Randomization), 6-and 12-month-Follow-up visit
|
Baseline (Randomization), 6-and 12-month-Follow-up visit
|
Changes in LV systolic and diastolic indexed volumes
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in right ventricular (RV) systolic and diastolic indexed volumes
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in LV and RV mass
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in LV sphericity index and LV end-systolic global wall stress
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in sleep duration and sleep stages as well as arousals
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in sleep-disordered breathing
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in quality of life assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ)
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in mental status assessed by Mini-Mental State Examination (MMSE)
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Changes in Patient Health Questionnaire-9 (PHQ-9) score and Patient Anxiety Questionnaire GAD-7
Time Frame: Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Baseline (Randomization), 6- and 12-month-Follow-up-visit
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Martin Cowie, Prof, Royal Brompton Hospital, London
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01a
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
Clinical Trials on adaptive servoventilation (ASV)
-
Philips Portuguesa S.A.Not yet recruiting
-
ResMedCompletedPeriodic Breathing | Breathing-Related Sleep DisorderGermany
-
Military Institute of Medicine, PolandUnknownCheyne-Stokes Respiration | Chronic Heart Failure | Central Sleep ApneaPoland
-
Ruhr University of BochumCompletedSleep Apnea Syndromes | Heart Failure, Congestive | Adaptive ServoventilationGermany
-
University Hospital RegensburgResMed FoundationTerminatedSleep Apnea | Acute Myocardial InfarctionGermany
-
Beth Israel Deaconess Medical CenterCompletedAcute Respiratory Distress SyndromeUnited States
-
ResMedTerminatedDiastolic Heart FailureGermany
-
Postgraduate Institute of Medical Education and...CompletedChronic Obstructive Pulmonary Disease | Invasive Mechanical Ventilation | Adaptive Support VentilationIndia
-
Toronto Rehabilitation InstituteCanadian Institutes of Health Research (CIHR); Philips RespironicsTerminatedHeart Failure | Sleep ApneaCanada, Spain, Japan, Germany, France, United States, Brazil, Italy, United Kingdom
-
ResMedCompletedCheyne-Stokes Respiration | Periodic BreathingGermany